EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY-NC 4.0

Polycystic ovary syndrome and risk of pre‐eclampsia: A national register‐based cohort study

Ragnheidur Valdimarsdottir, Eszter Vanky, Evangelia Elenis iD, Linda Lindström, Katja Junus, Maria Jonsson, Inger Sundström Poromaa, Anna-Karin Wikström

BJOG: An International Journal of Obstetrics & Gynaecology · 2024-06 · 131 (7) · 985-995

DOI: 10.1111/1471-0528.17734 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift BJOG: An International Journal of Obstetrics & Gynaecology, online erschienen am 11.12.2023. Verfasst von Ragnheidur Valdimarsdottir und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Women's and Children's Health, Uppsala University, Uppsala, Sweden. Hauptthemen laut MEDLINE: Polycystic Ovary Syndrome, Pre-Eclampsia, Registries, Hyperandrogenism. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: The Perinatal Foundation, Sweden, Swedish Research Council, Vetenskapsrådet.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To explore whether the association between polycystic ovary syndrome (PCOS) and pre‐eclampsia depends on treated clinical hyperandrogenism and whether PCOS is associated with different subtypes of pre‐eclampsia.

Design

Nationwide register‐based cohort study.

Setting

Sweden. Population Nulliparous women with PCOS ( n = 22 947) and non‐PCOS controls ( n = 115 272) giving singleton birth at ≥22 gestational weeks during 1997–2015. Treated clinical hyperandrogenism was defined as filled prescriptions of anti‐androgenic drugs during 2005–2017 ( n = 2301 among PCOS women).

Methods

The risk of pre‐eclampsia was estimated with conditional logistic regression, expressed as adjusted odds ratio (OR) with 95% confidence interval (CI). Adjustments were performed individually for confounders and predictors. Main outcome measures Overall pre‐eclampsia. Early/late (delivery

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Polycystic Ovary SyndromePre-EclampsiaRegistriesHyperandrogenismHumansFemalePregnancyAdultSwedenRisk FactorsInfant, Small for Gestational AgeCohort StudiesCase-Control StudiesInfant, NewbornYoung Adult

Stichwörter der Autor:innen

hyperandrogenismpolycystic ovary syndromepregnancy complicationspreterm birthpre‐eclampsiasmall for gestational age

Autor:innen und Institutionen

  • Department of Women's and Children's Health, Uppsala University, Uppsala, Sweden.
  • Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway.
  • Department of Obstetrics and Gynaecology, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway.

ORCID-Profile: Evangelia Elenis

Förderung

  • The Perinatal Foundation, Sweden
  • Swedish Research Council
  • Vetenskapsrådet

Zitieren

APA

Valdimarsdottir, R., Vanky, E., Elenis, E., Lindström, L., Junus, K., Jonsson, M., Sundström Poromaa, I., & Wikström, A. K. (2024). Polycystic ovary syndrome and risk of pre‐eclampsia: A national register‐based cohort study. BJOG: An International Journal of Obstetrics & Gynaecology, 131(7), 985-995. https://doi.org/10.1111/1471-0528.17734

Vancouver

Valdimarsdottir R, Vanky E, Elenis E, Lindström L, Junus K, Jonsson M, et al. Polycystic ovary syndrome and risk of pre‐eclampsia: A national register‐based cohort study. BJOG: An International Journal of Obstetrics & Gynaecology. 2024;131(7):985-995. doi:10.1111/1471-0528.17734

BibTeX
@article{Valdimarsdottir2024,
  author = {Valdimarsdottir, Ragnheidur and Vanky, Eszter and Elenis, Evangelia and Lindström, Linda and Junus, Katja and Jonsson, Maria and Sundström Poromaa, Inger and Wikström, Anna-Karin},
  title = {Polycystic ovary syndrome and risk of pre‐eclampsia: A national register‐based cohort study},
  journal = {BJOG: An International Journal of Obstetrics & Gynaecology},
  year = {2024},
  volume = {131},
  number = {7},
  pages = {985--995},
  doi = {10.1111/1471-0528.17734}
}
Kostenlos starten →